59
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients

, &
Pages 6871-6877 | Published online: 12 Oct 2018

References

  • SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
  • di CosimoSBaselgaJManagement of breast cancer with targeted agents: importance of heterogeneity. [corrected]Nat Rev Clin Oncol20107313914720125090
  • Metzger-FilhoOTuttAde AzambujaEDissecting the heterogeneity of triple-negative breast cancerJ Clin Oncol201230151879188722454417
  • YangQLiuHYLiuDSongYQUltrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypesAsian Pac J Cancer Prev20151683229323225921124
  • ChafferCLWeinbergRAA perspective on cancer cell metastasisScience201133160241559156421436443
  • ScullyOJBayBHYipGYuYBreast cancer metastasisCancer Genomics Proteomics20129531132022990110
  • SørlieTPerouCMTibshiraniRGene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProc Natl Acad Sci U S A20019819108691087411553815
  • LiuRZGarciaEGlubrechtDDPoonHYMackeyJRGodboutRCRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acidMol Cancer20151412926142905
  • BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
  • ChenKRajewskyNThe evolution of gene regulation by transcription factors and microRNAsNat Rev Genet2007829310317230196
  • LiPDongJZhouXExpression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancerOnco Targets Ther2017105711571829238203
  • HuangYJianWZhaoJWangGOverexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese femalesOnco Targets Ther2018112177218429713186
  • SinghRPMassachiIManickavelSThe role of miRNA in inflammation and autoimmunityAutoimmun Rev201312121160116523860189
  • ChenLSongJCuiJmicroRNAs regulate adipocyte differentiationCell Biol Int201337653354623504919
  • LuGJDongYQZhangQMmiRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinomaInt J Clin Exp Pathol2015855224522926191221
  • ViñasJLVentayolMBrüneBmiRNA let-7e modulates the Wnt pathway and early nephrogenic markers in mouse embryonic stem cell differentiationPLoS ONE201384e6093723593353
  • FaraziTAHoellJIMorozovPTuschlTMicroRNAs in human cancerAdv Exp Med Biol201377412023377965
  • FangYXGaoWQRoles of microRNAs during prostatic tumorigenesis and tumor progressionOncogene201433213514723455326
  • JiangCChenXAlattarMWeiJLiuHMicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancerCancer Gene Ther201522629130125998522
  • YaoYSuoALLiZFMicroRNA profiling of human gastric cancerMol Med Rep20092696397021475928
  • SandMSkryganMSandDExpression of microRNAs in basal cell carcinomaBr J Dermatol2012167484785522540308
  • XiaYWuYLiuBWangPChenYDownregulation of miR-638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLCFEBS Lett2014588142238224524842609
  • TanXPengJFuYmiR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancerBreast Cancer Res201416543525228385
  • HongWDongEThe past, present and future of breast cancer research in ChinaCancer Lett201435111524735750
  • NaumovGNTownsonJLMacdonaldICIneffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastasesBreast Cancer Res Treat200382319920614703067
  • DarwishADHelalAMAly El-DinNHSolaimanLLAminABreast cancer in women aging 35 years old and younger: the Egyptian National Cancer Institute (NCI) experienceBreast2017311827771499
  • SlaouiMMouhFZGhannameIRazineREl MzibriMAmraniMOutcome of breast ZC cancer in moroccan young women correlated to clinic-pathological features, risk factors and treatment: a comparative study of 716 cases in a single institutionPLoS ONE20161110e016484127760178
  • JagarlamudiKKShawMThymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarkerBiomark Med20181291035104830039979
  • GivechianKBGarnerCGarbanHRabizadehSSoon-ShiongPCAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinomaOncotarget2018951297432975230038717
  • ShidfarACostaFFScholtensDExpression of miR-18a and miR-210 in normal breast tissue as candidate biomarkers of breast cancer riskCancer Prev Res20171018997
  • MarquesMMEvangelistaAFMacedoTExpression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancerClinics201873e18429995098
  • HeMLinYTangYmiR-638 suppresses DNA damage repair by targeting SMC1A expression in terminally differentiated cellsAging2016871442145627405111
  • ZavalaVPérez-MorenoETapiaTCamusMCarvalloPmiR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survivalCancer Biomark20161619910726835710
  • ZhangJFeiBWangQMicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinomaOncotarget2014523120831209625301729
  • ZhaoLYTongDDXueMMeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1Oncogenesis201767e36828759023